Cross-posted from TargetHIVExit Disclaimer

PrEPcost.orgExit Disclaimer, the online tool for PrEP navigators and clients to evaluate the cost and coverage of pre-exposure prophylaxis (PrEP) for HIV prevention, has been updated for the 2019 Open Enrollment period. PrEPcost.org includes most states; others will be added as data become available.

The updated PrEPcost.org allows for searching for providers (doctors, clinics) and their acceptance of specific health plans, filtering of plans by metal level/cost, and comparison of plans. (The site advices users to contact their clinics/doctors to verify which plans they accept. Users should also verify PrEPcost.org results against information from their state enrollment website or healthcare.gov.) PrEPcost.org was developed by NASTAD with support from Gilead Sciences.

HRSA’s HIV/AIDS Bureau (HAB), in a June 2016 Dear Colleague letter, strongly encouraged "Ryan White HIV/AIDS Program (RWHAP) recipients and providers to leverage the RWHAP infrastructure to support PrEP services within the parameters of the RWHAP legislation." The letter further explains that RWHAP funds cannot be used "for PrEP medications and the related medical services such as physician visits and laboratory costs."

See the introductory webinar below, the PrEPcost.org training webinarExit Disclaimer, and an explanation of Copay a Policies and a fact sheetExit Disclaimer (which is when “an insurance plan or its pharmacy refuses to count a manufacturer co-pay card or similar programs towards that person’s deductible or plan annual out-of-pocket maximum"). 

Questions and Comments? Email PrEP@NASTAD.org.